Ionis Pharmaceuticals, Inc.
MODULATION OF ALPHA SYNUCLEIN EXPRESSION

Abstract:

Disclosed herein are antisense compounds and methods for decreasing alpha-synuclein mRNA and protein expression. Also disclosed herein are methods for treating, preventing, and ameliorating neurodegenerative diseases in an individual in need thereof.